Striking the Balance: How Much Should Your Business Spend on R&D?

Oct 15, 2024

The ideal percentage of budget allocated for Research & Development (R&D) varies widely depending on the industry, competitive dynamics, emerging technologies, and the lifecycle of existing technologies. High-tech industries (e.g., pharma, software) tend to allocate a larger percentage, while traditional or slower-evolving industries (e.g., consumer packaged goods, energy) allocate less but may increase R&D in response to industry disruptions (e.g., renewable energy transition).

A one-size-fits-all solution is not possible in this case. Below is a breakdown of typical R&D spending across different industries optimized from empirical lessons, along with the context for competition, technological advancements, and expiring technologies:

The pharmaceutical industry is highly R&D-intensive due to the need for constant innovation in drug development, long clinical trial processes, and patent expirations. The emergence of new biotechnologies and therapies drives higher R&D investment. Ideally, 15%–25% of revenue should be earmarked for R&D. Key factors are patent expiration, regulatory requirements, and breakthroughs in biomedicine (e.g., gene editing, personalized medicine).

Rapid innovation and competition characterize the technology sector, particularly in software, hardware, and AI development. Companies like Google, Microsoft, and Apple heavily invest in R&D to stay ahead in emerging technologies like AI, quantum computing, and blockchain. Expiring or obsolete technologies (e.g., older software versions) drive constant reinvestment. 15%–25% of revenue should be set aside for R&D.

With the transition to electric vehicles (EVs), autonomous driving, and smart mobility, R&D is focused on next-gen automotive technologies. Traditional automakers are shifting budgets to compete with tech-forward firms like Tesla. A pragmatic range of investment would be 5%–10% of revenue.

High levels of R&D are needed for advanced aerospace technologies (e.g., space exploration, military innovations). The share of R&D budget could be in the range of 10%–15% of revenue.

The consumer electronics industry is driven by product life cycles and demand for innovation in devices like smartphones, wearables, and home electronics. Competition from emerging market players and short technology lifespans push firms to invest in R&D to create the next big product. The share for R&D in the annual budget could ideally be 8%–12% of revenue.

R&D in materials/chemicals focuses on developing new materials, improving sustainability, and addressing regulatory pressures related to environmental impact. 7%–12% should necessarily be dedicated to R&D.

Companies in medical devices invest in R&D to develop cutting-edge technologies such as robotic surgery, wearable health tech, and minimally invasive devices. It would be ideal if companies earmarked 7%–12% of revenue on research and development.

R&D in CPG focuses on product differentiation, sustainability, and adapting to changing consumer preferences. It is ideal to spend 1%–4% of revenue on research.

Traditional energy companies invest in R&D for efficiency improvements in oil and gas extraction, while renewable energy firms focus on innovations in solar, wind, and energy storage. It is good to invest 2%–5% of revenue in this field.

R&D in telecom is centered on upgrading networks (e.g., 5G, 6G, fibre optics) and developing new communications technologies. An optimum range of investments would be 5%–8% of revenue.

AI companies, particularly those involved in machine learning, natural language processing, computer vision, and autonomous systems, invest heavily in R&D due to rapid advancements and intense competition. Ideal annual investment range would be 15%–30% of revenue.

Robotics companies are focused on developing advanced robotics for industrial automation, healthcare, consumer products, and autonomous systems (e.g., drones, autonomous vehicles). The budget share in R&D could be 10%–25% of revenue.

The semiconductor industry is highly R&D-intensive due to the need for constant innovation in chip design, process technology, and materials science. Competition is fierce, with the industry driven by Moore's Law, and the emergence of new technologies like AI, 5G, quantum computing, and advanced manufacturing techniques. 10%–20% of revenue would be ideal for R&D.

It is of vital importance to allocate a reasonable amount in R&D for survival and competitive edge. Depending on the industry, the share could be between 3% to 25%. In extreme cases, it can be as high as 30%. The need for continuous innovation in design, process technologies, and materials to overcome the limits of and meet the demands of emerging markets is always there, more so in the domains of AI, 5G, pharma, medical devices, and autonomous vehicles.

Our professional services offer training and support to minimise time-to-value on the Relecura platform and make more timely, confident IP decisions.